Jove
Visualize
联系我们

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Robust Rapid Cellular Metabolite Sensing Using Benchtop NMR and SABRE-Hyperpolarized [1-<sup>13</sup>C]Pyruvate.

Analytical chemistry·2026
Same author

Biocompatible SABRE Hyperpolarization of [1-<sup>13</sup>C]Ketoleucine for Cellular Metabolic Flux Sensing.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Multidimensional pH-Temperature Mapping of SABRE-SHEATH <sup>13</sup>C Hyperpolarization of [1-<sup>13</sup>C]Pyruvate.

The journal of physical chemistry. B·2025
Same author

Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM-HET3 Mice and Attenuates Alzheimer's-Like Pathology.

Aging cell·2025
Same author

Lifelong restriction of dietary valine has sex-specific benefits for health and lifespan in mice.

bioRxiv : the preprint server for biology·2025
Same author

Liver injury severity determines skeletal deterioration: a shared pathophysiological axis between MASLD and osteoarthritis.

GeroScience·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Dulmalika Navodya Herath Manchanayake1, Hashan S M Jayarathne1, Marianna Sadagurski1

  • 1Wayne State University, Detroit, MI, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括

糖尿病药物canagliflozin在治疗阿尔茨海默病 (AD) 方面表现有前途,通过减少大脑病理和改善雄性小鼠的认知能力. 这种-葡萄糖共运输体2抑制剂 (SGLT2i) 可能为神经退行性疾病提供新的治疗途径.

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.
  • 衰老研究研究 衰老研究

背景情况:

  • 老龄化是阿尔茨海默病 (AD) 的一个主要风险因素,治疗选择有限.
  • 卡纳格里弗洛辛 (Cana) 是一种-葡萄糖共运输体2抑制剂 (SGLT2i),以前在雄性小鼠中延长了寿命,并显示出神经保护作用.
  • 在年龄较大的雄性小鼠中,Cana显示了胰岛素反应的改善,神经炎症的减少和行为增强.

研究的目的:

  • 调查Canagliflozin (Cana) 在缓解AD相关病理方面的潜力.
  • 评估Cana对AD小鼠模型认知功能,神经炎症和粉样β (Aβ) 负担的影响.

主要方法:

  • 使用了AD的5XFAD鼠标模型.
  • 从3个月起,使用含卡纳的饮食.
  • 在6-7个月大时进行代谢,行为和组织学分析,以评估Aβ负担,神经炎症和海马功能.

主要成果:

  • 在雄性和雌性5XFAD小鼠中,Cana改善了葡萄糖耐受性.
  • 雄性5XFAD小鼠表现出增强的认知表现和空间记忆.
  • 在雄性小鼠中,Cana显著降低了海马Aβ斑块负担和神经炎症.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

结论:

  • -葡萄糖共运输体2抑制剂 (SGLT2i) 在缓解AD病理方面发挥着新的作用.
  • 在神经退行性疾病的治疗中,SGLT2i显示出对重新利用的前景.
  • 研究结果强调了Cana对AD的潜在治疗益处,特别是在男性中.